MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 30 filers reported holding MYMD PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $863,311 | -60.5% | 1,458,295 | 0.0% | 0.00% | – |
| Q2 2023 | $2,187,443 | -12.8% | 1,458,295 | 0.0% | 0.00% | – |
| Q1 2023 | $2,508,267 | +49.6% | 1,458,295 | 0.0% | 0.00% | – |
| Q4 2022 | $1,677,039 | -55.9% | 1,458,295 | +0.0% | 0.00% | – |
| Q3 2022 | $3,804,000 | +20.3% | 1,457,655 | 0.0% | 0.00% | – |
| Q2 2022 | $3,163,000 | -53.4% | 1,457,655 | 0.0% | 0.00% | – |
| Q1 2022 | $6,792,000 | -23.5% | 1,457,655 | -0.5% | 0.00% | – |
| Q4 2021 | $8,877,000 | -19.1% | 1,464,763 | -3.8% | 0.00% | – |
| Q3 2021 | $10,968,000 | +14.1% | 1,523,304 | -0.1% | 0.00% | – |
| Q2 2021 | $9,609,000 | – | 1,525,321 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Praetorian Wealth Management, Inc. | 200,000 | $118,400 | 0.04% |
| Atlas Brown,Inc. | 43,500 | $25,752 | 0.01% |
| Taylor & Morgan Wealth Management, LLC | 16,086 | $9,523 | 0.01% |
| Fidelis Capital Partners, LLC | 38,590 | $22,845 | 0.01% |
| Cambria Investment Management, L.P. | 171,570 | $101,569 | 0.01% |
| Corundum Group, Inc. | 19,600 | $11,603 | 0.01% |
| Bridgecreek Investment Management, LLC | 30,000 | $17,760 | 0.00% |
| XTX Topco Ltd | 39,544 | $23,410 | 0.00% |
| WALLED LAKE PLANNING & WEALTH MANAGEMENT, LLC | 14,000 | $8,288 | 0.00% |
| NWAM LLC | 40,000 | $23,680 | 0.00% |